Skip to main content
About the Institute
  • English
  • Français
  • Español
  • Russian
  • Portuguese
  • Polish
  • Turkish

Breadcrumb

  1. Home
  2. Gastroenterology
  3. Irritable bowel syndrome: role of Brachyspira revealed
  • Our publications
    • News
    • Microbiota Mag
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographics
    • IBS Diagnosis Check List
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

Lay public section

Find here your dedicated section
Gastroenterology
Gynecology
Pediatrics
Dermatology

Breadcrumb

  1. Home
  2. Gastroenterology
  3. Irritable bowel syndrome: role of Brachyspira revealed
Gastroenterology

Irritable bowel syndrome: role of Brachyspira revealed

IBS
Gastroenterology

The presence of Brachyspira in the colonic mucosa of some patients suffering from irritable bowel syndrome–now demonstrated for the first time–may be associated with certain symptoms of the disease, such as diarrhea.

Gastroenterology
Gynecology
Pediatrics
Dermatology
  • Our publications
    • News
    • Microbiota Mag
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographics
    • IBS Diagnosis Check List
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

Lay public section

Find here your dedicated section

Sources

This article is based on scientific information

Sharing is caring

Your colleagues might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • LinkedIn
  • Mail
Actu PRO : Syndrome de l’intestin irritable : le rôle de Brachyspira dévoilé

About this article

Created 16 February 2021
Updated 04 March 2022

The incidence of irritable bowel syndrome (IBS) increases following gastroenteritis episodes, suggesting that gut dysbiosis could play a role in its onset. However, research to date has focused on the microbiota of the intestinal lumen and has failed to find any clear link between the composition of this microbiota and IBS. Changing strategy, a team analyzed the bacteria present in the mucus lining of the colonic epithelium rather than that present in the lumen. This was done via sigmoid colon mucus samples taken from patients with IBS (with diarrhea, with constipation, with mixed bowel habits or unclassified) and controls.

Peptides indicating the presence of Brachyspira

Metaproteomic analyses on an explorative cohort (22 patients, 14 controls) identified microbial peptides derived from potentially pathogenic Brachyspira species in the mucus of 3/22 patients with IBS. Electron microscopy was used to confirm the presence of this bacterium, both at the colonocyte apical membrane and in the mucus. Quantitative real-time PCR (qPCR) combined with immunofluorescence analyses on the entire cohort (62 patients, 31 controls) detected Brachyspira colonization in 31% of IBS patients and in 42% of patients with diarrheal forms of the disease. No such colonization was observed in the controls.

Brachyspira colonizes colonocytes

The presence of Brachyspira specifically in the colonocyte apical membrane (as opposed to the mucus) was observed in 21% of the patients, and was associated with increased diarrhea and accelerated transit. These patients presented mild mucosal inflammation and mast cell activation. In addition, the abundance of mast cells was correlated with abdominal pain scores.

Antibiotics counterproductive?

In a final experiment, the researchers tested the effects of metronidazole in four patients. One year after treatment, three out of four saw a reduction in IBS severity. However, although Brachyspira was cleared from the epithelial surface, its presence in crypts and goblet cells may represent a novel mechanism of antiobiotic resistance. In conclusion, Brachyspira colonization in IBS (particularly at colonocyte level) appears to be associated with specific clinical, metabolic, and immune responses, thus providing a potential diagnostic tool for the different forms of IBS. In addition, antibiotic therapy in cases of IBS should be considered with caution due to the potential bacterial colonization that it could later cause.

Sources

Jabbar KS, Dolan B, Eklund L et al. Association between Brachyspira and irritable bowel syndrome with diarrhoea. Gut. 2021 Jun;70(6):1117-1129.

Tags
Antibiotics Dysbiosis Irritable bowel syndrome IBS Diarrhea Spirochetes

en_view en_sources

    Created 16 February 2021
    Updated 04 March 2022

    About this article

    To know more about this topic.

    Main topic

    IBS

    Medical practice

    Gastroenterology

    Content type

    News
    Gastroenterology

    A pan-cancer mycobiome analysis reveals fungal involvement in gastrointestinal and lung tumours

    COMMENTED ARTICLE - ADULTS’ SECTION By Pr. Harry S...

    Find out more

    Artificial sweeteners, gut microbiota and metabolic health: an interaction requiring close examination

    By Pr. Karine ClémentSorbonne University, Inserm, U...

    Find out more

    Gut Microbiota #18

    By Pr. Satu PekkalaAcademy of Finland Research Fellow, Faculty of Sport and Health Sciences, Universi...

    Find out more

    Highlights of Gut Microbiota for Health - World Summit 2023

    By Dr. Nicolas BenechGastroenterology and hepatology, Microbiota Study Group, Hospices Civils de Lyon...

    Find out more

    Rural environment reduces allergic inflammation by modulating the gut microbiota

    Commented article - Children's section By Pr. Emma...

    Find out more

    Everything you need to know about Irritable Bowel Syndrome (IBS)

    Accrediting training, infographics, expert’s video,...

    Find out more

    Your IBS Diagnosis Check List

    How many patients suffering from gut disorder do you see per week? How many are diagnosed with Irrita...

    Find out more

    Human milk nutrient fortifiers alter the developing gastrointestinal microbiota of very-low-birth-weight infants

    Commented article - Children's section By Pr. Emma...

    Find out more

    Continue reading

    News
    Everything you need to know about the microbiota gut-brain axis
    22.05.2023

    Everything you need to know about the microbiota gut-brain axis

    Read the article
    SII, microbiote intestinal et dépression : un triptyque pour mieux comprendre la maladie
    27.07.2022

    IBS, gut microbiota and depression: a trio shedding light on the disease

    Read the article
    Actu PRO : Cancer du poumon : le microbiote intestinal signerait un stade précoce
    02.07.2020

    Gut microbiota could be an indicator of early-stage lung cancer

    Read the article
    Obesity: Is a bacterial fatty acid involved?
    15.05.2023

    Obesity: Is a bacterial fatty acid involved?

    Read the article
    Photo: Endométriose : une clé de sa progression au sein du microbiote intestinal
    09.05.2023

    Endometriosis: A key to its progression in the gut microbiota?

    Read the article
    16.11.2022

    Alcohol use disorders: in microbiota veritas?

    Read the article
    Photo: Atténuer la dénutrition avec des biotiques ?
    26.04.2023

    Mitigating malnutrition with biotics?

    Read the article
    25.04.2023

    F. prausnitzii : a biomarker of chronic fatigue syndrome

    Read the article
    What's worth reading about microbiota
    Follow us on Twitter
    Read our thematic folder
    The Janus face of Antibiotics: Life Savers & Microbiota Disrupters
    Microbiota 17 EN
    Check out our latest magazine
    The first 1000 days of life
    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      • IBS Diagnosis Check List
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section
    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology
    • English
    • Français
    • Español
    • Russian
    • Portuguese
    • Polish
    • Turkish

    Browse the site

    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      • IBS Diagnosis Check List
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

    Lay public section

    Find here your dedicated section

    Redirection

    You are about to be redirected and leave our website

    • Be redirected
    • Stay on the Biocodex Microbiota Institute's website

    Stay with us !

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    Artificial sweeteners, gut microbiota and metabolic health: an interaction requiring close examination

    By Pr. Karine ClémentSorbonne University, Inserm, U...

    Find out more

    Urinary and Urethral Microbiota #18

    By Pr. Satu PekkalaAcademy of Finland Research Fellow, Faculty of Sport and Health Sciences, Universi...

    Find out more

    Vaginal Microbiota #18

    By Pr. Satu PekkalaAcademy of Finland Research Fellow, Faculty of Sport and Health Sciences, Universi...

    Find out more

    Stay updated

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      • IBS Diagnosis Check List
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Lay public section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

    © 2022 Biocodex. All rights reserved.

    • Cookies Policy
    • Data protection policy
    • GTU
    • Sitemap
    • Cookies settings
    Biocodex logo